Neurocrine Biosciences Reports Fourth Quarter and Full-Year 2020 Financial Results
Go back to Neurocrine Biosciences Reports Fourth Quarter and Full-Year 2020 Financial Results| Neurocrine Biosciences, Inc. (NASDAQ: NBIX) | Delayed: 176.43 -1.06 (0.6%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $177.49 | 52 Week High | $58.46 | |||
| Open | $177.70 | 52 Week Low | $31.25 | |||
| Day High | $178.56 | P/E | N/A | |||
| Day Low | $176.25 | EPS | $-0.69 | |||
| Volume | 263,579 | |||||
